Tudor: A versatile family of histone methylation 'readers'

Trends in Biochemical Sciences

Volumn 38, Issue 11, 2013, Pages 546-555

  Lu, Rui ^a   Wang, Gang Greg ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

53BP1; Epigenetic reader; Histone methylation; JMJD2A; PHF1; PHF19; SGF29; SHH1; Spindlin1; Tudor domain; UHRF1

Indexed keywords

BINDING PROTEIN; HISTONE; HOMEODOMAIN PROTEIN; JUMONJI DOMAIN CONTAINING 2A PROTEIN; LAMIN B RECEPTOR; LIGASE; MEMBRANE PROTEIN; NUCLEAR PROTEIN; P53 BINDING PROTEIN 1; PHD FINGER PROTEIN 1; PHD FINGER PROTEIN 19; SAGA ASSOCIATED FACTOR 29; SAWADEE HOMEODOMAIN HOMOLOG 1 PROTEIN; SPINDLIN1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SAGA; UBIQUITIN LIKE WITH PHD AND RING FINGER DOMAIN 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; DNA DAMAGE; DNA REPAIR; GENETIC REGULATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; TRANSCRIPTION REGULATION; TUDOR DOMAIN;

53BP1; EPIGENETIC READER; HISTONE METHYLATION; JMJD2A; PHF1; PHF19; SGF29; SHH1; SPINDLIN1; TUDOR DOMAIN; UHRF1;

ANIMALS; DNA METHYLATION; DROSOPHILA; DROSOPHILA PROTEINS; HISTONES; MEMBRANE TRANSPORT PROTEINS; MODELS, MOLECULAR;

EID: 84885848767     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2013.08.002     Document Type: Review

References (109)

1. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
2. Taverna S.D., et al. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 2007, 14:1025-1040.
3. Ruthenburg A.J., et al. Multivalent engagement of chromatin modifications by linked binding modules. Nat. Rev. Mol. Cell Biol. 2007, 8:983-994.
4. Musselman C.A., et al. Perceiving the epigenetic landscape through histone readers. Nat. Struct. Mol. Biol. 2012, 19:1218-1227.
5. Chi P., et al. Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 2010, 10:457-469.
6. Wang G.G., et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009, 459:847-851.
7. Wang G.G., et al. Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol. Med. 2007, 13:363-372.
8. Baker L.A., et al. PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutat. Res. 2008, 647:3-12.
9. Matthews A.G., et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 2007, 450:1106-1110.
10. Iwase S., et al. ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nat. Struct. Mol. Biol. 2011, 18:769-776.
11. Zeng L., Zhou M.M. Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 2002, 513:124-128.
12. Lan F., et al. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 2007, 448:718-722.
13. Pena P.V., et al. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 2006, 442:100-103.
14. Li H., et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 2006, 442:91-95.
15. Ruthenburg A.J., et al. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol. Cell 2007, 25:15-30.
16. Shi X., et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 2006, 442:96-99.
17. Wysocka J., et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 2006, 442:86-90.
18. Boswell R.E., Mahowald A.P. tudor, a gene required for assembly of the germ plasm in Drosophila melanogaster. Cell 1985, 43:97-104.
19. Callebaut I., Mornon J.P. The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development. Biochem. J. 1997, 321:125-132.
20. Ponting C.P. Tudor domains in proteins that interact with RNA. Trends Biochem. Sci. 1997, 22:51-52.
21. Chen C., et al. Deciphering arginine methylation: Tudor tells the tale. Nat. Rev. Mol. Cell Biol. 2011, 12:629-642.
22. Pek J.W., et al. Tudor domain proteins in development. Development 2012, 139:2255-2266.
23. Jacobs S.A., Khorasanizadeh S. Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science 2002, 295:2080-2083.
24. Selenko P., et al. SMN tudor domain structure and its interaction with the Sm proteins. Nat. Struct. Biol. 2001, 8:27-31.
25. Friesen W.J., et al. SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets. Mol. Cell 2001, 7:1111-1117.
26. Sprangers R., et al. High-resolution X-ray and NMR structures of the SMN Tudor domain: conformational variation in the binding site for symmetrically dimethylated arginine residues. J. Mol. Biol. 2003, 327:507-520.
27. Sanders S.L., et al. Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage. Cell 2004, 119:603-614.
28. Huang Y., et al. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science 2006, 312:748-751.
29. Botuyan M.V., et al. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 2006, 127:1361-1373.
30. Bian C., et al. Sgf29 binds histone H3K4me2/3 and is required for SAGA complex recruitment and histone H3 acetylation. EMBO J. 2011, 30:2829-2842.
31. Vermeulen M., et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010, 142:967-980.
32. Yang N., et al. Distinct mode of methylated lysine-4 of histone H3 recognition by tandem tudor-like domains of Spindlin1. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:17954-17959.
33. Wang W., et al. Nucleolar protein Spindlin1 recognizes H3K4 methylation and stimulates the expression of rRNA genes. EMBO Rep. 2011, 12:1160-1166.
34. Rothbart S.B., et al. Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation. Nat. Struct. Mol. Biol. 2012, 19:1155-1160.
35. Arita K., et al. Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:12950-12955.
36. Liu X., et al. UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9. Nat. Commun. 2013, 4:1563.
37. Rothbart S.B., et al. Multivalent histone engagement by the linked tandem Tudor and PHD domains of UHRF1 is required for the epigenetic inheritance of DNA methylation. Genes Dev. 2013, 27:1288-1298.
38. Cai L., et al. An H3K36 methylation-engaging Tudor motif of Polycomb-like proteins mediates PRC2 complex targeting. Mol. Cell 2013, 49:571-582.
39. Musselman C.A., et al. Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1. Nat. Struct. Mol. Biol. 2012, 19:1266-1272.
40. Qin S., et al. Tudor domains of the PRC2 components PHF1 and PHF19 selectively bind to histone H3K36me3. Biochem. Biophys. Res. Commun. 2013, 430:547-553.
41. Brien G.L., et al. Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation. Nat. Struct. Mol. Biol. 2012, 19:1273-1281.
42. Ballare C., et al. Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity. Nat. Struct. Mol. Biol. 2012, 19:1257-1265.
43. Law J.A., et al. Polymerase IV occupancy at RNA-directed DNA methylation sites requires SHH1. Nature 2013, 10.1038/nature12178.
44. Tang J., et al. Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination. Nat. Struct. Mol. Biol. 2013, 20:317-325.
45. Mallette F.A., et al. RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J. 2012, 31:1865-1878.
46. Shi Y., Whetstine J.R. Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 2007, 25:1-14.
47. Klose R.J., et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 2006, 442:312-316.
48. Lee J., et al. Distinct binding modes specify the recognition of methylated histones H3K4 and H4K20 by JMJD2A-tudor. Nat. Struct. Mol. Biol. 2008, 15:109-111.
49. Noon A.T., Goodarzi A.A. 53BP1-mediated DNA double strand break repair: insert bad pun here. DNA Repair (Amst.) 2011, 10:1071-1076.
50. Kachirskaia I., et al. Role for 53BP1 Tudor domain recognition of p53 dimethylated at lysine 382 in DNA damage signaling. J. Biol. Chem. 2008, 283:34660-34666.
51. Roy S., et al. Structural insight into p53 recognition by the 53BP1 tandem Tudor domain. J. Mol. Biol. 2010, 398:489-496.
52. Ward I.M., et al. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol. Cell. Biol. 2003, 23:2556-2563.
53. Du L.L., et al. Histone modification-dependent and -independent pathways for recruitment of checkpoint protein Crb2 to double-strand breaks. Genes Dev. 2006, 20:1583-1596.
54. Aly A., Ganesan S. BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability. J. Mol. Cell Biol. 2011, 3:66-74.
55. Cao L., et al. A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. Mol. Cell 2009, 35:534-541.
56. Bunting S.F., et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 2010, 141:243-254.
57. Sanders S.L., et al. Requirement for the phospho-H2AX binding module of Crb2 in double-strand break targeting and checkpoint activation. Mol. Cell. Biol. 2010, 30:4722-4731.
58. Samara N.L., Wolberger C. A new chapter in the transcription SAGA. Curr. Opin. Struct. Biol. 2011, 21:767-774.
59. Zhao Q., et al. Structure of human spindlin1. Tandem tudor-like domains for cell cycle regulation. J. Biol. Chem. 2007, 282:647-656.
60. Bartke T., et al. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 2010, 143:470-484.
61. Bostick M., et al. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317:1760-1764.
62. Sharif J., et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450:908-912.
63. Arita K., et al. Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 2008, 455:818-821.
64. Avvakumov G.V., et al. Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 2008, 455:822-825.
65. Hashimoto H., et al. The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 2008, 455:826-829.
66. Nady N., et al. Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein. J. Biol. Chem. 2011, 286:24300-24311.
67. Rottach A., et al. The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res. 2010, 38:1796-1804.
68. Bracken A.P., Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 2009, 9:773-784.
69. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
70. Cao R., et al. Role of hPHF1 in H3K27 methylation and Hox gene silencing. Mol. Cell. Biol. 2008, 28:1862-1872.
71. Sarma K., et al. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Mol. Cell. Biol. 2008, 28:2718-2731.
72. Nekrasov M., et al. Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes. EMBO J. 2007, 26:4078-4088.
73. Shen X., et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009, 139:1303-1314.
74. Hunkapiller J., et al. Polycomb-like 3 promotes polycomb repressive complex 2 binding to CpG islands and embryonic stem cell self-renewal. PLoS Genet. 2012, 8:e1002576.
75. Savla U., et al. Recruitment of Drosophila Polycomb-group proteins by Polycomblike, a component of a novel protein complex in larvae. Development 2008, 135:813-817.
76. Casanova M., et al. Polycomblike 2 facilitates the recruitment of PRC2 Polycomb group complexes to the inactive X chromosome and to target loci in embryonic stem cells. Development 2011, 138:1471-1482.
77. Sun B., et al. Molecular basis of the interaction of Saccharomyces cerevisiae Eaf3 chromo domain with methylated H3K36. J. Biol. Chem. 2008, 283:36504-36512.
78. Xu C., et al. Structural basis for the recognition of methylated histone H3K36 by the Eaf3 subunit of histone deacetylase complex Rpd3S. Structure 2008, 16:1740-1750.
79. Wu H., et al. Structural and histone binding ability characterizations of human PWWP domains. PLoS ONE 2011, 6:e18919.
80. Vezzoli A., et al. Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. Nat. Struct. Mol. Biol. 2010, 17:617-619.
81. Tzatsos A., et al. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs. J. Clin. Invest. 2013, 123:727-739.
82. Voigt P., et al. Asymmetrically modified nucleosomes. Cell 2012, 151:181-193.
83. Olins A.L., et al. Lamin B receptor: multi-tasking at the nuclear envelope. Nucleus 2010, 1:53-70.
84. Hirano Y., et al. Lamin B receptor recognizes specific modifications of histone H4 in heterochromatin formation. J. Biol. Chem. 2012, 287:42654-42663.
85. Solovei I., et al. LBR and lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation. Cell 2013, 152:584-598.
86. Liokatis S., et al. Solution structure and molecular interactions of lamin B receptor Tudor domain. J. Biol. Chem. 2012, 287:1032-1042.
87. Ruthenburg A.J., et al. Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell 2011, 145:692-706.
88. Rajakumara E., et al. PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol. Cell 2011, 43:275-284.
89. Cheng J., et al. Structural insight into coordinated recognition of trimethylated histone H3 lysine 9 (H3K9me3) by the plant homeodomain (PHD) and tandem tudor domain (TTD) of UHRF1 (ubiquitin-like, containing PHD and RING finger domains, 1) protein. J. Biol. Chem. 2013, 288:1329-1339.
90. Dawson M.A., Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012, 150:12-27.
91. Arrowsmith C.H., et al. Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug Discov. 2012, 11:384-400.
92. Filippakopoulos P., et al. Selective inhibition of BET bromodomains. Nature 2010, 468:1067-1073.
93. Dawson M.A., et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011, 478:529-533.
94. Zuber J., et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011, 478:524-528.
95. Delmore J.E., et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011, 146:904-917.
96. Berry W.L., Janknecht R. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res. 2013, 73:2936-2942.
97. Bronner C., et al. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?. Pharmacol. Ther. 2007, 115:419-434.
98. Wang S., et al. A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers. Gene 2004, 343:69-78.
99. Panagopoulos I., et al. Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma. PLoS ONE 2012, 7:e39354.
100. Baylin S.B. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. 2005, 2(Suppl. 1):S4-S11.
101. James L.I., et al. Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. Nat. Chem. Biol. 2013, 9:184-191.
102. Eberl H.C., et al. A map of general and specialized chromatin readers in mouse tissues generated by label-free interaction proteomics. Mol. Cell 2013, 49:368-378.
103. Spruijt C.G., et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152:1146-1159.
104. Rothbart S.B., et al. Peptide microarrays to interrogate the "histone code". Methods Enzymol. 2012, 512:107-135.
105. Yang Y., et al. TDRD3 is an effector molecule for arginine-methylated histone marks. Mol. Cell 2010, 40:1016-1023.
106. Adams-Cioaba M.A., et al. Crystal structures of the Tudor domains of human PHF20 reveal novel structural variations on the Royal Family of proteins. FEBS Lett. 2012, 586:859-865.
107. Cui G., et al. PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53. Nat. Struct. Mol. Biol. 2012, 19:916-924.
108. Cote J., Richard S. Tudor domains bind symmetrical dimethylated arginines. J. Biol. Chem. 2005, 280:28476-28483.
109. Liu K., et al. Crystal structure of TDRD3 and methyl-arginine binding characterization of TDRD3, SMN and SPF30. PLoS ONE 2012, 7:e30375.